Jin Lu, Li Peiyun, Tang Youli, Yin Wanhong, Wang Fang, Zhang Ling
Division of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, China.
Department of Critical Care Medicine, Wenjiang District People's Hospital, Chengdu, China.
Ren Fail. 2025 Dec;47(1):2537810. doi: 10.1080/0886022X.2025.2537810. Epub 2025 Jul 29.
Net ultrafiltration (UF) is widely used for fluid management during continuous renal replacement therapy (CRRT) for critically ill patients over extended periods. Despite widespread use, the relationship between UF intensity and clinical outcomes, particularly mortality, remains controversial.
This retrospective observational study examined critically ill patients undergoing CRRT for more than 72 h from January 2021 to September 2023. Patients were stratified by their UF intensity during the initial 72 h of CRRT into low (<1.01 mL/kg/h), moderate (1.01-1.75 mL/kg/h), and high (>1.75 mL/kg/h) groups. The primary outcome was 28-day mortality. Kaplan-Meier's survival curves with log-rank tests, Cox proportional hazards models, and propensity score matching were employed to assess the association between UF intensity and mortality.
A total of 683 patients were included. Compared with the moderate UF intensity, the low UF intensity (adjusted hazard ratio (HR) 1.54, 95%CI 1.24-1.91, = .024) and high UF intensity (adjusted HR 1.27, 95%CI 1.03-1.57, < .001) were associated with higher 28-day mortality. Sensitivity analyses showed similar trends for 60-day and 90-day mortality. Subgroup analyses based on admission diagnosis did not reveal significant differences in the effect of UF intensity on mortality risk.
UF intensity between 1.01 and 1.75 mL/kg/h during the first 72 h of CRRT was associated with lower 28-day mortality compared to both lower and higher UF intensities. However, future studies are needed to better define optimal UF thresholds in multicenter ICU cohorts.
在危重症患者的持续肾脏替代治疗(CRRT)过程中,净超滤(UF)被广泛用于长期的液体管理。尽管使用广泛,但超滤强度与临床结局,尤其是死亡率之间的关系仍存在争议。
这项回顾性观察性研究对2021年1月至2023年9月期间接受CRRT超过72小时的危重症患者进行了检查。根据CRRT初始72小时内的超滤强度,将患者分为低超滤强度组(<1.01 mL/kg/h)、中超滤强度组(1.01 - 1.75 mL/kg/h)和高超滤强度组(>1.75 mL/kg/h)。主要结局是28天死亡率。采用Kaplan-Meier生存曲线结合对数秩检验、Cox比例风险模型和倾向评分匹配来评估超滤强度与死亡率之间的关联。
共纳入683例患者。与中超滤强度相比,低超滤强度(调整后风险比(HR)1.54,95%置信区间1.24 - 1.91,P = 0.024)和高超滤强度(调整后HR 1.27,95%置信区间1.03 - 1.57,P < 0.001)与28天死亡率较高相关。敏感性分析显示60天和90天死亡率有类似趋势。基于入院诊断的亚组分析未发现超滤强度对死亡风险的影响有显著差异。
与较低和较高的超滤强度相比,CRRT前72小时内超滤强度在1.01至1.75 mL/kg/h之间与较低的28天死亡率相关。然而,未来需要进一步研究以更好地确定多中心重症监护病房队列中的最佳超滤阈值。